Yujie Lei Selected Research

Yujie Lei Research Topics

Disease

15	Lung Neoplasms (Lung Cancer) 01/2024 - 02/2010
10	Neoplasms (Cancer) 02/2024 - 08/2008
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 09/2009
2	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2019
2	Adenocarcinoma of Lung 11/2023 - 08/2008
2	Infections 01/2021 - 07/2010
2	Carcinogenesis 12/2020 - 01/2016
2	Adenocarcinoma 12/2020 - 01/2019
1	Melanoma (Melanoma, Malignant) 02/2024
1	Intraoperative Complications 12/2023
1	Postoperative Hemorrhage 12/2023
1	Chemical and Drug Induced Liver Injury 09/2022
1	Inflammation (Inflammations) 09/2022
1	Cytokine Release Syndrome 01/2022
1	Neurotoxicity Syndromes (Toxic Encephalopathy) 01/2022
1	Tumor Lysis Syndrome 01/2022
1	Sepsis (Septicemia) 01/2021
1	Chronic Renal Insufficiency 05/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Hyperplasia 08/2015
1	Carcinoma (Carcinomatosis) 08/2015
1	Metaplasia 08/2015
1	Stroke (Strokes) 08/2014
1	Pulmonary Embolism 08/2014
1	Healthcare-Associated Pneumonia 08/2014
1	Pneumothorax 08/2014
1	Pulmonary Atelectasis 08/2014
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2014
1	Infarction (Infarctions) 08/2014
1	Cardiac Arrhythmias (Arrythmia) 08/2014
1	Congenital Abnormalities (Deformity) 09/2012

Drug/Important Bio-Agent (IBA)

6	Coal (Coals)IBA 01/2019 - 05/2010
4	Particulate MatterIBA 05/2020 - 07/2015
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2017
3	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2017
2	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2020
2	AntigensIBA 01/2022 - 01/2022
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2022
2	Biocompatible Materials (Biomaterials)IBA 01/2021 - 07/2010
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 04/2014
2	Polyvinyl Chloride (PVC)IBA 09/2012 - 07/2010
1	RNA (Ribonucleic Acid)IBA 02/2024
1	Circular RNAIBA 01/2024
1	CholesterolIBA 12/2023
1	Hyaluronic Acid (Hyaluronan)IBA 12/2023
1	Phosphatidylcholines (Phosphatidylcholine)IBA 12/2023
1	Liposomes (Liposome)IBA 12/2023
1	celastrolIBA 12/2023
1	Oxidants (Oxidizing Agents)IBA 09/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 09/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2022
1	EmulsionsIBA 01/2021
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2021
1	LipidsIBA 01/2021
1	CateninsIBA 12/2020
1	Interleukin-33IBA 12/2020
1	VimentinIBA 12/2020
1	FH535IBA 12/2020
1	Cadherins (E-Cadherin)IBA 12/2020
1	AntibodiesIBA 01/2020
1	CarcinogensIBA 01/2019
1	Iodized OilIBA 03/2016
1	SuspensionsIBA 03/2016
1	InterleukinsIBA 01/2016
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2016
1	SolventsIBA 08/2015
1	Oxygen (Dioxygen)IBA 08/2014
1	antiarrhythmic peptide (AAP)IBA 04/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2014
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 04/2014
1	Silicon Dioxide (Silica)FDA LinkGeneric 10/2012
1	DNA AdductsIBA 05/2010
1	Glutathione (Reduced Glutathione)IBA 08/2008
1	SeleniumIBA 08/2008

Therapy/Procedure

3	Therapeutics 12/2023 - 01/2022
2	Immunotherapy 01/2022 - 01/2022
1	Length of Stay 12/2023
1	Catheters 01/2021
1	Psychosurgery (Lobotomy) 02/2010
1	Drug Therapy (Chemotherapy) 09/2009